Trials / Completed
CompletedNCT02387723
CSCC_ASC Therapy in Patients With Severe Heart Failure
Allogeneic Adipose Tissue-derived Stromal/Stem Cell Therapy in Patients With Ischemic Heart Disease and Heart Failure - a Safety Study
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- JKastrup · Academic / Other
- Sex
- All
- Age
- 30 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The present aim is to perform at small clinical safety trial in heart failure patients with allogeneic adipose tissue derived mesenchymal stem cells.
Detailed description
Patients with heart failure will be treated with culture expanded adipose tissue derived mesenchymal stem cells from healthy donors stored in nitrogen until use. The cells will be injected directly into the myocardium using the NOGA XP method. The patients will be followed for 6 months for safety and efficacy registration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Allogeneic adipose derived stem cells (CSCC_ASC) | Culture expanded allogeneic adipose derive stem cells (CSCC\_ASC) |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2015-11-01
- Completion
- 2015-11-01
- First posted
- 2015-03-13
- Last updated
- 2016-02-02
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02387723. Inclusion in this directory is not an endorsement.